NEW YORK (GenomeWeb News) – Invitrogen and Applied Biosystems today said that European Union regulatory authorities have cleared their proposed $6.7 billion merger.
 
The deal already cleared US antitrust hurdles and is expected to close on Nov. 21, the firms said.
 
ABI stockholders have until the end of the business day on Nov. 19 to elect whether they will receive all cash, all stock, or a mix of the two in consideration for their shares.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.